The proposed epidemiologic study will evaluate the contribution of environmental and genetic factors to the etiology of Parkinson's disease (PD). Of particular interest are substances that are similar in chemical structure or mechanism of action to established toxicants for secondary parkinsonism, a disorder that shares some clinical and pathologic features with idiopathic PD. The focus will be on Settings where high dose or chronic exposure may have taken place, specifically, the agricultural environment, industrial settings, diet and the home. A putative biomarker of genetic susceptibility of impaired toxicant metabolism, the CYP2D6 gene that encodes for the P450 enzyme debrisoquine hydroxylase, will be measured. This is a common enzymatic pathway for the metabolism of many of the neurotoxicants under study. The role of putative protective factors (i.e. dietary antioxidants, cigarette smoking, skin pigmentation) that may minimize the toxicity of exogenous exposures will also be evaluated. We propose to conduct a case-control study of incident PD cases identified within the Kaiser Permanente Medical Care Program (KPMCP) of Northern California. Over a three-year period, physician referrals and computerized records will be used to maximize the ascertainment of newly diagnosed cases of PD. Approximately 600 cases will be enrolled, and compared to an equal number of control subjects selected from computerized KPMCP membership files (individually matched to cases by gender, age, KPMCP service area). Study information will be collected by structured interview and will include: demographic characteristics, residence history, lifetime occupational history, hobbies, home exposures, illicit and prescription drug use, family history, cigarette smoking, and dietary habits. Blood samples will be drawn for CYP2D6 genotyping. Conditional logistic regression will be used to provide odds ratio estimates for the exposures of interest. The collection of detailed information regarding the duration and timing of environmental exposures will enable the evaluation of dose-response trends and the estimation of latent periods between putative exposure and the development of Parkinson's disease. It is hoped that the proposed study will advance knowledge of potential neurotoxic and genetic risk factors for PD in a racially and geographically diverse population.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS031964-02
Application #
2269935
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1994-06-01
Project End
1998-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Stanford University
Department
Miscellaneous
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Kwee, Lydia Coulter; Liu, Yutao; Haynes, Carol et al. (2012) A high-density genome-wide association screen of sporadic ALS in US veterans. PLoS One 7:e32768
McGuire, V; Van Den Eeden, S K; Tanner, C M et al. (2011) Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. J Neurol Sci 307:22-9
Popat, R A; Van Den Eeden, S K; Tanner, C M et al. (2011) Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol 18:756-65
Shino, Michael Y; McGuire, Valerie; Van Den Eeden, Stephen K et al. (2010) Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study. Mov Disord 25:2587-94
Lo, Raymond Y; Tanner, Caroline M; Van Den Eeden, Stephen K et al. (2010) Comorbid cancer in Parkinson's disease. Mov Disord 25:1809-17
Elbaz, Alexis; Nelson, Lorene M; Payami, Haydeh et al. (2006) Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol 5:917-23
Popat, R A; Van Den Eeden, S K; Tanner, C M et al. (2005) Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology 65:383-90
Van Den Eeden, Stephen K; Tanner, Caroline M; Bernstein, Allan L et al. (2003) Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157:1015-22
Checkoway, H; Nelson, L M (1999) Epidemiologic approaches to the study of Parkinson's disease etiology. Epidemiology 10:327-36
Whittemore, A S; Nelson, L M (1999) Study design in genetic epidemiology: theoretical and practical considerations. J Natl Cancer Inst Monogr :61-9

Showing the most recent 10 out of 11 publications